A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
Since 1996, the nicotine patch has been re-classified from prescription to over-the-counter (OTC) status in the United States. Little is known about how the public uses the OTC nicotine patch due to lack of monitoring. The purpose of this observational study is to describe the characteristics of consumers who purchase OTC nicotine patches from community pharmacies and to determine the factors associated with the appropriate use of nicotine patches.
Tobacco Use Disorder
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Usage Patterns of OTC Nicotine Patches: Consumer Survey|
|Study Start Date:||September 2005|
|Study Completion Date:||November 2006|
|Primary Completion Date:||May 2006 (Final data collection date for primary outcome measure)|
The nicotine patch is an effective aid for smoking cessation. Since 1996, the nicotine patch has been re-classified from prescription to over-the-counter (OTC) status in the United States. Unlike prescription medications, post-marketing surveillance does not exist for OTC medications. The purpose of this study is to describe the characteristics of consumers who purchase OTC nicotine patches from community pharmacies and to determine the factors associated with appropriate use of nicotine patches.
This prospective, cross-sectional, observational study will include a survey of 600 consumers who purchase OTC nicotine patches at a random sample of 30 community retail pharmacies. Consumers will be recruited by an ad located in the pharmacy next to the nicotine patch product. Participants will fill out a self-administered, anonymous questionnaire at the time of OTC nicotine patch purchase at the pharmacy counter. The questionnaire will gather information about demographics, medical history, smoking history, attitudes toward the nicotine patch, and motivation to quit smoking. No study visits will be required for this study.
|United States, California|
|Department of Family and Preventive Medicine|
|La Jolla, California, United States, 92093|
|Principal Investigator:||Chih-Wen Shi, M.D., M.S.||University of California, San Diego|